Novavax (NVAX) Non Operating Income (2014 - 2026)

Novavax's Non Operating Income history runs 13 years deep, the most recent figure standing at $11.8 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 17.59% year-over-year to $11.8 million; the TTM figure through Mar 2026 stood at $42.4 million (down 9.48% YoY), while the FY2025 annual figure was $40.6 million, changed 0.47% from the prior year.
• Non Operating Income was $11.8 million for Q1 2026 at Novavax, up from $9.5 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $64.0 million in Q4 2022 to a low of -$34.8 million in Q3 2022.
• Historically, Non Operating Income has averaged $8.3 million across 5 years, with a median of $9.5 million in 2025.
• Biggest YoY gain for Non Operating Income was 14639.86% in 2022; the steepest drop was 756.31% in 2022.
• A 5-year view of Non Operating Income shows it stood at $64.0 million in 2022, then plunged by 82.83% to $11.0 million in 2023, then rose by 19.58% to $13.1 million in 2024, then retreated by 27.7% to $9.5 million in 2025, then gained by 24.51% to $11.8 million in 2026.
• The last three Non Operating Income figures came in at $11.8 million (Q1 2026), $9.5 million (Q4 2025), and $9.2 million (Q3 2025), per Business Quant data.